ArticleCancer cell international2021

Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer.

Zaoqu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.